ERYTHROCIN

This brand name is authorized in Canada, Ireland, Japan, Malta, South Africa

Active ingredients

The drug ERYTHROCIN contains one active pharmaceutical ingredient (API):

1 Erythromycin UNII 63937KV33D - ERYTHROMYCIN

Erythromycin exerts its antimicrobial action by binding to the 50S ribosomal sub-unit of susceptible microorganisms and suppresses protein synthesis. Erythromycin is bacteriostatic and bactericidal depending on its concentration and the type of organism. Read about Erythromycin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ERYTHROCIN Film coated tablets	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01FA01	Erythromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02326663
Country: IE	Health Products Regulatory Authority	Identifier(s): 23809, 23892, 64076, 82627
Country: JP	医薬品医療機器総合機構	Identifier(s): 6141001D1033, 6141001R1120, 6141001R2053, 6141004F1038, 6141004F2042
Country: MT	Medicines Authority	Identifier(s): AA565/11210
Country: ZA	Health Products Regulatory Authority	Identifier(s): F/20.1.1/109